Cyclerion Therapeutics (CYCN) Assets (2019 - 2025)
Historic Assets for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $10.4 million.
- Cyclerion Therapeutics' Assets rose 1704.88% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year increase of 1704.88%. This contributed to the annual value of $9.6 million for FY2024, which is 2840.59% down from last year.
- Per Cyclerion Therapeutics' latest filing, its Assets stood at $10.4 million for Q3 2025, which was up 1704.88% from $9.4 million recorded in Q2 2025.
- Over the past 5 years, Cyclerion Therapeutics' Assets peaked at $100.0 million during Q1 2021, and registered a low of $8.9 million during Q3 2024.
- Its 5-year average for Assets is $28.8 million, with a median of $13.4 million in 2023.
- In the last 5 years, Cyclerion Therapeutics' Assets crashed by 7537.67% in 2023 and then skyrocketed by 1704.88% in 2025.
- Over the past 5 years, Cyclerion Therapeutics' Assets (Quarter) stood at $59.3 million in 2021, then plummeted by 69.53% to $18.1 million in 2022, then fell by 26.02% to $13.4 million in 2023, then fell by 28.41% to $9.6 million in 2024, then rose by 8.77% to $10.4 million in 2025.
- Its Assets stands at $10.4 million for Q3 2025, versus $9.4 million for Q2 2025 and $9.8 million for Q1 2025.